UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

High-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease

Neurology, 2009-04, Vol.72 (16), p.1378-1384

2009

Volltextzugriff (PDF)

Fatigue in levodopa-naive subjects with Parkinson disease

Neurology, 2008-08, Vol.71 (7), p.481

2008

Volltextzugriff (PDF)

Comparison of botulinum toxin serotypes A and B for the treatment of cervical dystonia

Neurology, 2005-11, Vol.65 (9), p.1423-1429

2005

Volltextzugriff (PDF)

Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD

Neurology, 2003-01, Vol.60 (1), p.69-73

2003

Volltextzugriff (PDF)

Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

Neurology, 2008-05, Vol.70 (19), p.1699-1706

2008

Volltextzugriff (PDF)

Cognitive performance of GBA mutation carriers with early-onset PD: the CORE-PD study

Neurology, 2012-05, Vol.78 (18), p.1434-1440

2012

Volltextzugriff (PDF)

Social Skills and Cognitive Training to Support Work-Related Skills and Job Placement in a Group of Autistic Adults: Effectiveness of a Neuropsychological and Social Skills Intervention: A Case Series Study on a Pilot Program

Community mental health journal, 2023-11, Vol.59 (8), p.1610-1618

2023

Volltextzugriff (PDF)

Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia

Neurology, 1999-10, Vol.53 (7), p.1431-1431

1999

Volltextzugriff (PDF)

Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia

Neurology, 1999-10, Vol.53 (7), p.1439-1439

1999

Volltextzugriff (PDF)

The treatment of cervical dystonia with botulinum toxins

Journal of Neural Transmission, 2008-04, Vol.115 (4), p.579-583

Comella, C. L.

2008

Volltextzugriff (PDF)

Longitudinal outcome of Parkinson's disease patients with psychosis

Neurology, 2003-06, Vol.60 (11), p.1756-1761

2003

Volltextzugriff (PDF)

Clinico-immunologic aspects of botulinum toxin type B treatment of cervical dystonia

Neurology, 2006-12, Vol.67 (12), p.2233-2235

2006

Volltextzugriff (PDF)

A randomized, double masked, controlled trial of botulinum toxin type A in essential hand tremor

Neurology, 2001-06, Vol.56 (11), p.1523-1528

2001

Volltextzugriff (PDF)

Clinicopathological findings following intraventricular glial-derived neurotrophic factor treatment in a patient with Parkinson's disease

Annals of neurology, 1999-09, Vol.46 (3), p.419-424

1999

Volltextzugriff (PDF)

Sleep-related violence, injury, and REM sleep behavior disorder in Parkinson's disease

Neurology, 1998-08, Vol.51 (2), p.526-529

1998

Volltextzugriff (PDF)

Treatment of focal dystonias with botulinum neurotoxin

Toxicon (Oxford), 2009-10, Vol.54 (5), p.628-633

2009

Volltextzugriff (PDF)

Treatment of cervical dystonia with botulinum toxins

European journal of neurology, 2006-02, Vol.13 (s1), p.16-20

2006

Volltextzugriff (PDF)

Olfaction in Parkin heterozygotes and compound heterozygotes: the CORE-PD study

Neurology, 2011-01, Vol.76 (4), p.319-326

2011

Volltextzugriff (PDF)

Basic clinical features do not predict dopamine transporter binding in idiopathic REM behavior disorder

NPJ Parkinson's Disease, 2019-01, Vol.5 (1), p.2-2, Article 2

2019

Volltextzugriff (PDF)

Sleep disturbances and excessive daytime sleepiness in Parkinson disease: an overview

Journal of neural transmission. Supplementum, 2006 (70), p.349

Comella, C L

2006

Volltextzugriff (PDF)

The Dystonia Coalition: Four years of progress

Journal of the neurological sciences, 2013-10, Vol.333, p.e132-e132

2013

Volltextzugriff (PDF)

Polysomnographic sleep measures in Parkinson's disease patients with treatment-induced hallucinations

Annals of neurology, 1993-11, Vol.34 (5), p.710-714

1993

Volltextzugriff (PDF)

The relation between depression and parkin genotype: The CORE-PD study

Parkinsonism & related disorders, 2011-12, Vol.17 (10), p.740-744

2011

Volltextzugriff (PDF)

S20-5 Movement and brain function in essential tremor and Parkinson's disease

Clinical neurophysiology, 2010, Vol.121, p.S33-S33

2010

Volltextzugriff (PDF)

Teaching tape for the motor section of the toronto western spasmodic torticollis scale

Movement disorders, 1997-07, Vol.12 (4), p.570-575

1997

Volltextzugriff (PDF)

1 – 25 von 364

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(339)
Mit Volltextzugriff
(279)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(214)
Life Sciences & Biomedicine
(205)
Humans
(179)
Female
(117)
Male
(117)
Biological And Medical Sciences
(108)
Middle Aged
(107)
Medical Sciences
(98)
Aged
(88)
Neurosciences & Neurology
(85)
Clinical Neurology
(72)
Adult
(70)
Pharmacology. Drug Treatments
(54)
Neurology
(51)
Oncology
(42)
Antineoplastic Agents
(31)
Treatment Outcome
(30)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(29)
Animals
(27)
Neurosciences
(27)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

High-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease

Fatigue in levodopa-naive subjects with Parkinson disease

Comparison of botulinum toxin serotypes A and B for the treatment of cervical dystonia

Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD

Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

Cognitive performance of GBA mutation carriers with early-onset PD: the CORE-PD study

Social Skills and Cognitive Training to Support Work-Related Skills and Job Placement in a Group of Autistic Adults: Effectiveness of a Neuropsychological and Social Skills Intervention: A Case Series Study on a Pilot Program

Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia

Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia

The treatment of cervical dystonia with botulinum toxins

Longitudinal outcome of Parkinson's disease patients with psychosis

Clinico-immunologic aspects of botulinum toxin type B treatment of cervical dystonia

A randomized, double masked, controlled trial of botulinum toxin type A in essential hand tremor

Clinicopathological findings following intraventricular glial-derived neurotrophic factor treatment in a patient with Parkinson's disease

Sleep-related violence, injury, and REM sleep behavior disorder in Parkinson's disease

Treatment of focal dystonias with botulinum neurotoxin

Treatment of cervical dystonia with botulinum toxins

Olfaction in Parkin heterozygotes and compound heterozygotes: the CORE-PD study

Basic clinical features do not predict dopamine transporter binding in idiopathic REM behavior disorder

Sleep disturbances and excessive daytime sleepiness in Parkinson disease: an overview

The Dystonia Coalition: Four years of progress

Polysomnographic sleep measures in Parkinson's disease patients with treatment-induced hallucinations

The relation between depression and parkin genotype: The CORE-PD study

S20-5 Movement and brain function in essential tremor and Parkinson's disease

Teaching tape for the motor section of the toronto western spasmodic torticollis scale

Suchergebnisse filtern